Literature DB >> 3982404

Studies of the purine analog associated modulation of human erythrocyte acid phosphatase activity.

K H Wurzinger, J E Novotny, H W Mohrenweiser.   

Abstract

The activity of the human erythrocyte acid phosphatase is modulated by a series of structural analogs of purine. The unsubstituted purine base does not affect the enzyme activity. Addition of a substituent at the number six position usually generates an analog which activates the enzyme while similar substitutions at the two position usually generate an inhibitor. Pyrimidines are generally ineffective as modulators while several modifications of the imidazole ring of the purine analogs do not abolish the modulator activity of the purine analog. The level of response to all active analogs is isozyme specific. Differences in apparent relative affinities among the modulators are noted. The modulators with a positive effect on enzyme activity, are effective in the presence of methanol which is more effective than H2O as a phosphate acceptor. These analogs act by enhancing the rate of transfer of phosphate to H2O, while decreasing the rate of transfer to methanol. The results suggest that the purine analogs may act by altering the rate of hydrolysis of the phosphoenzyme intermediate by H2O or may change the rate-limiting step in the catalytic mechanism.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3982404     DOI: 10.1007/bf00220780

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  31 in total

1.  An improved assay for nanomole amounts of inorganic phosphate.

Authors:  P A Lanzetta; L J Alvarez; P S Reinach; O A Candia
Journal:  Anal Biochem       Date:  1979-11-15       Impact factor: 3.365

2.  Activation of low molecular weight acid phosphatase from bovine brain by purines and glycerol.

Authors:  M M Tanizaki; H M Bittencourt; H Chaimovich
Journal:  Biochim Biophys Acta       Date:  1977-11-23

3.  A homogeneous isoenzyme of human liver acid phosphatase.

Authors:  M S Saini; R L Van Etten
Journal:  Arch Biochem Biophys       Date:  1978-12       Impact factor: 4.013

4.  A comparison of some properties of human red cell acid phosphatase in different phenotypes.

Authors:  J E Luffman; H Harris
Journal:  Ann Hum Genet       Date:  1967-05       Impact factor: 1.670

5.  Erythrocyte acid phosphatase: species specificity in activity modulation by purine analogs.

Authors:  J M Naidu; H W Mohrenweiser
Journal:  Comp Biochem Physiol B       Date:  1985

6.  ACP1GUA-1--a low-activity variant of human erythrocyte acid phosphatase: association with increased glutathione reductase activity.

Authors:  H W Mohrenweiser; J E Novotny
Journal:  Am J Hum Genet       Date:  1982-05       Impact factor: 11.025

7.  The genetic component of quantitative perinatal variables. An analysis of relations between erythrocyte acid phosphatase phenotype and birth weight, gestational age and serum bilirubin level in the first days of life.

Authors:  E Carapella; R Pascone; M G Gori; P Matteucci; F Gloria-Bottini; J Mortera; P Lucarelli; R Scacchi; E Bottini
Journal:  J Perinat Med       Date:  1980       Impact factor: 1.901

8.  Stereochemistry of phospho transfer catalyzed by bovine liver acid phosphatase.

Authors:  M S Saini; S L Buchwald; R L Van Etten; J R Knowles
Journal:  J Biol Chem       Date:  1981-10-25       Impact factor: 5.157

9.  Phenotype dependence in the inhibition of red cell acid phosphatase (ACP) by folates.

Authors:  G F Sensabaugh; V L Golden
Journal:  Am J Hum Genet       Date:  1978-09       Impact factor: 11.025

10.  Favism: association with erythrocyte acid phosphatase phenotype.

Authors:  E Bottini; P Lucarelli; R Agostino; R Palmarino; L Businco; G Antognoni
Journal:  Science       Date:  1971-01-29       Impact factor: 47.728

View more
  1 in total

1.  Interaction at clinical level between erythrocyte acid phosphatase and adenosine deaminase genetic polymorphisms.

Authors:  F Gloria-Bottini; P Lucarelli; A Amante; N Lucarini; G Finocchi; E Bottini
Journal:  Hum Genet       Date:  1989-06       Impact factor: 4.132

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.